<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00282815</url>
  </required_header>
  <id_info>
    <org_study_id>K23NS051202</org_study_id>
    <nct_id>NCT00282815</nct_id>
  </id_info>
  <brief_title>Sleep Apnea Treatment After Stroke (SATS)</brief_title>
  <official_title>Treatment of Obstructive Sleep Apnea After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if treating stroke patients who have obstructive
      sleep apnea with continuous positive airway pressure will improve symptoms caused by the
      stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the leading cause of adult disability in the United States, yet there are very few
      treatments that improve stroke outcome. Obstructive sleep apnea (OSA)--frequent upper airway
      blockage that occurs during sleep--is common after stroke, affecting more than half of stroke
      patients. The most common treatment for obstructive sleep apnea in the general population is
      nasal continuous positive airway pressure (CPAP) applied through a nasal mask during the
      hours of sleep. Positive air pressure holds the naso-oro-pharyngeal airway open during sleep.

      The objective of this single-center, prospective, randomized study is to evaluate CPAP
      treatment in post-stroke patients. Participants will go through a medical interview, a brief
      neurological examination, and a sleep study to screen them for OSA. Those with OSA will be
      eligible for the second phase of the study during which participants will be randomly
      selected to receive either treatment with CPAP or with sham CPAP (placebo).

      This project promises to establish feasibility, develop design and identify suitable outcome
      measures (e.g. hours of CPAP treatment per week, functional outcome, depression, fatigue, and
      impaired alertness) for a large-scale clinical trial of CPAP in stroke patients with OSA. If
      the larger trial shows benefits of CPAP, a new treatment for more than half of all stroke
      patients will become available.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruitment. Funding expired.
  </why_stopped>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Continuous Positive Airway Pressure (CPAP)/Sham CPAP Usage Hours Over the 3 Month Period.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects Who Withdraw From Study.</measure>
    <time_frame>3 months</time_frame>
    <description>Prespecified outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>3 months</time_frame>
    <description>Barthel Index score range: 0 (worst, fully dependent) - 100 (best, independent).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham CPAP (placebo)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure or CPAP</intervention_name>
    <description>RemStar Pro (Respironics, Inc.) The CPAP is applied through a nasal mask during the hours of sleep. Positive air pressure holds the naso-oro-pharyngeal airway open during sleep.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham CPAP</intervention_name>
    <description>sham CPAP</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic stroke within 7 days of planned polysomnography/sleep screening study

          -  Modified Rankin Scale score &gt;1

          -  If of child-bearing potential, has a negative urine or serum pregnancy test

        Exclusion Criteria:

          -  Decompensated heart failure

          -  Cardiac or respiratory arrest within the past 3 months

          -  Myocardial infarction within the past 3 months

          -  Severe pneumonia

          -  Hypertension refractory to treatment

          -  Any other unstable medical condition which is thought to interfere with participation

          -  Known preexisting OSA already on CPAP or previously failed CPAP or used CPAP

          -  Previous pneumothorax

          -  Bullous emphysema

          -  Chronic obstructive pulmonary disease (COPD), obesity-hypoventilation, or another
             condition warranting the use of nasal bilevel positive airway pressure instead of CPAP

          -  Acute sinus or ear infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Devin Brown, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor, Stroke Program, University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lewis Morgenstern, MD</last_name>
    <role>Study Director</role>
    <affiliation>Director, Stroke Program, University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jack Kalbfleisch, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan Dept of Biostatistics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Brown DL, Chervin RD, Kalbfleisch JD, Zupancic MJ, Migda EM, Svatikova A, Concannon M, Martin C, Weatherwax KJ, Morgenstern LB. Sleep apnea treatment after stroke (SATS) trial: is it feasible? J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1216-24. doi: 10.1016/j.jstrokecerebrovasdis.2011.06.010. Epub 2011 Jul 23.</citation>
    <PMID>21784661</PMID>
  </results_reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2006</study_first_submitted>
  <study_first_submitted_qc>January 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2006</study_first_posted>
  <results_first_submitted>June 21, 2011</results_first_submitted>
  <results_first_submitted_qc>January 31, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 11, 2013</results_first_posted>
  <last_update_submitted>January 31, 2013</last_update_submitted>
  <last_update_submitted_qc>January 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Devin Brown</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>stroke</keyword>
  <keyword>OSA</keyword>
  <keyword>CPAP</keyword>
  <keyword>continuous positive airway pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients enrolled from inpatient neurology service.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Active Continuous Positive Airway Pressure (CPAP)</title>
        </group>
        <group group_id="P2">
          <title>Sham Continuous Positive Airway Pressure (CPAP)</title>
          <description>Subtherapeutic CPAP</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Continuous Positive Airway Pressure (CPAP)</title>
        </group>
        <group group_id="B2">
          <title>Sham Continuous Positive Airway Pressure (CPAP)</title>
          <description>Subtherapeutic CPAP</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" spread="16"/>
                    <measurement group_id="B2" value="74" spread="16"/>
                    <measurement group_id="B3" value="65" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Continuous Positive Airway Pressure (CPAP)/Sham CPAP Usage Hours Over the 3 Month Period.</title>
        <time_frame>3 months</time_frame>
        <population>Data not available on one sham participant (lowering n from 11 to 10 in the shame group).</population>
        <group_list>
          <group group_id="O1">
            <title>Active CPAP</title>
          </group>
          <group group_id="O2">
            <title>Sham CPAP</title>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Continuous Positive Airway Pressure (CPAP)/Sham CPAP Usage Hours Over the 3 Month Period.</title>
          <population>Data not available on one sham participant (lowering n from 11 to 10 in the shame group).</population>
          <units>Hours/participant</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="22" upper_limit="173"/>
                    <measurement group_id="O2" value="74" lower_limit="17" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects Who Withdraw From Study.</title>
        <description>Prespecified outcome.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>After Randomization</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Who Withdraw From Study.</title>
          <description>Prespecified outcome.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Barthel Index</title>
        <description>Barthel Index score range: 0 (worst, fully dependent) - 100 (best, independent).</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Continuous Positive Airway Pressure (CPAP)</title>
          </group>
          <group group_id="O2">
            <title>Sham Continuous Positive Airway Pressure (CPAP)</title>
            <description>Subtherapeutic CPAP</description>
          </group>
        </group_list>
        <measure>
          <title>Barthel Index</title>
          <description>Barthel Index score range: 0 (worst, fully dependent) - 100 (best, independent).</description>
          <units>units on a scale (range 0-100)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="90" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="95" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active Continuous Positive Airway Pressure (CPAP)</title>
        </group>
        <group group_id="E2">
          <title>Sham Continuous Positive Airway Pressure (CPAP)</title>
          <description>Subtherapeutic CPAP</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Attrition pre-randomization and while in randomized treatment led to small numbers.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Devin Brown, MD</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-936-9075</phone>
      <email>devinb@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

